Summary Biocept, Inc. (Biocept) is a medical equipment company that provides diagnostics services. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers OncoCEE technology, related instrumentation and analytical capabilities for rare event detection and genetic characterization. The company's OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company caters to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Biocept, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Biocept, Inc. Company Snapshot 5 Biocept, Inc. Company Overview 5 Biocept, Inc. Pipeline Products and Clinical Trials Overview 6 Biocept, Inc. - Pipeline Analysis Overview 8 Key Facts 8 Biocept, Inc. - Major Products and Services 9 Biocept, Inc. Pipeline Products by Development Stage 10 Biocept, Inc. Pipeline Products Overview 12 CTC Based Liquid Biopsy Test - ESR1 12 CTC Based Liquid Biopsy Test - ESR1 Product Overview 12 ctDNA Based Liquid Biopsy Test - ESR1 13 ctDNA Based Liquid Biopsy Test - ESR1 Product Overview 13 MicroRNA Test - Lung Cancer 14 MicroRNA Test - Lung Cancer Product Overview 14 OncoCEE - CR (FISH) 15 OncoCEE - CR (FISH) Product Overview 15 preCEED 16 preCEED Product Overview 16 Biocept, Inc. - Key Competitors 17 Biocept, Inc. - Key Employees 18 Biocept, Inc. - Locations And Subsidiaries 19 Head Office 19 Recent Developments 20 Biocept, Inc., Recent Developments 20 May 31, 2016: Biocept Launches Liquid Biopsy Immuno-Oncology PD-L1 Test 20 May 25, 2016: High Sensitivity of Biocept's Target Selector Blood-Based Liquid Biopsy Tests Featured in Two Abstracts at ASCO 20 May 23, 2016: Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests 21 May 19, 2016: Biocept Launches Proprietary Liquid Biopsy Test to Detect RET Fusions in Patients with Lung Cancer 21 May 12, 2016: Biocept Expands Intellectual Property Portfolio with 12th Granted Patent on its Key Liquid Biopsy Technology 22 May 12, 2016: Biocept Reports 2016 First Quarter Financial Results 22 Apr 27, 2016: Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study 23 Mar 23, 2016: Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award 24 Mar 10, 2016: Progenetics to Distribute Biocept's Liquid Biopsy Assays in Israel 24 Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results 24 Appendix 27 Methodology 27 About GlobalData 27 Contact Us 27 Disclaimer 27
List of Tables
Biocept, Inc. Pipeline Products and Clinical Trials Overview 6 Biocept, Inc. Pipeline Products by Equipment Type 6 Biocept, Inc. Pipeline Products by Indication 7 Biocept, Inc., Key Facts 8 Biocept, Inc., Major Products and Services 9 Biocept, Inc. Number of Pipeline Products by Development Stage 10 Biocept, Inc. Pipeline Products Summary by Development Stage 11 CTC Based Liquid Biopsy Test - ESR1 - Product Status 12 CTC Based Liquid Biopsy Test - ESR1 - Product Description 12 ctDNA Based Liquid Biopsy Test - ESR1 - Product Status 13 ctDNA Based Liquid Biopsy Test - ESR1 - Product Description 13 MicroRNA Test - Lung Cancer - Product Status 14 MicroRNA Test - Lung Cancer - Product Description 14 OncoCEE - CR (FISH) - Product Status 15 OncoCEE - CR (FISH) - Product Description 15 preCEED - Product Status 16 preCEED - Product Description 16 Biocept, Inc., Key Employees 18
List of Figures
Biocept, Inc. Pipeline Products by Equipment Type 7 Biocept, Inc. Pipeline Products by Development Stage 10
Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growtRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiencyRead More...
Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in cRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.